Simvastatin
Zocor | FloLipid
Overview
Simvastatin is an HMG-CoA reductase inhibitor (statin) used to lower LDL cholesterol and triglycerides and to reduce the risk of cardiovascular events.
Indications
- Primary hyperlipidemia
- Mixed dyslipidemia
- Prevention of cardiovascular events
- Homozygous familial hypercholesterolemia
Contraindications
- Active liver disease
- Pregnancy and breastfeeding
- Concomitant use of strong CYP3A4 inhibitors
Classification
Mechanism of Action
Competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis, upregulating LDL receptors and increasing clearance of LDL from the blood.
Pharmacodynamics
Lowers total and LDL cholesterol and triglycerides and modestly raises HDL cholesterol. Simvastatin is a prodrug that is hydrolyzed to its active beta-hydroxy acid form.
Pharmacokinetics
- Absorption
- Well absorbed but extensive first-pass hepatic extraction limits systemic availability.
- Distribution
- Highly protein bound; extensive uptake by the liver.
- Metabolism
- Extensively metabolized by CYP3A4 to active and inactive metabolites.
- Excretion
- Primarily excreted in feces via bile; minor renal elimination.
- Half-life
- 2-3 hours (active metabolite)
- Bioavailability
- Less than 5% (high first-pass metabolism)
- Protein Binding
- Approximately 95%
Dosage
Typical dosage: 10-40 mg once daily in the evening
Available Forms
- Tablet
- Oral suspension
Side Effects
Common
- Headache
- Myalgia
- Constipation
- Elevated liver enzymes
Serious
- Rhabdomyolysis
- Myopathy
- Hepatotoxicity
Rare
- Immune-mediated necrotizing myopathy
Drug Interactions
Strong CYP3A4 inhibition markedly increases simvastatin levels and the risk of myopathy and rhabdomyolysis.
Increases simvastatin exposure; the simvastatin dose should not exceed 20 mg daily.
Warnings
Pregnancy
Category X
Toxicity
Overdose is generally well tolerated; the main concern is dose-related myopathy and hepatotoxicity.
Overdose
No specific antidote. Provide supportive care and monitor liver enzymes and creatine kinase.
References
Looking for patient-friendly information? Visit RemedyDoor for easy-to-read guides about this medication.